Legend Biotech Corporation

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 10 10 18 19 12 12 12 41 14 20 17 39 41 12 27 28 36 73 96 79 94 187 160 187 195
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 14.9% 15.0% -33.54% 109.7% 18.5% 74.4% 43.7% -4.38% 198.4% -40.83% 62.1% -29.14% -11.00% 512.6% 250.9% 187.6% 158.7% 154.4% 66.9% 134.7% 107.5%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -419.46% 100.0% 100.0% 100.0% -99.25% -41.50% 6.9% 16.9% 2.0% 55.4% 54.7% 52.4% 35.7% 73.0% 65.4% 60.4% 63.4%
Koszty i Wydatki (mln) 25 39 48 80 57 68 79 100 93 108 103 156 115 131 171 155 161 176 188 201 212 228 160 261 246
EBIT (mln) -12 -29 -31 -60 -44 -56 -67 -56 -80 -89 -128 -91 -75 -119 -143 319 -107 -89 -67 -121 -118 -42 0 -74 -51
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 254.6% 92.0% 119.0% -6.55% 81.0% 59.3% 90.4% 62.0% -5.73% 33.6% 11.5% 449.1% 42.5% -25.67% -53.07% -137.92% 10.3% -53.14% -100.00% -38.54% -57.03%
EBIT (%) -123.27% -289.38% -173.67% -310.47% -380.62% -483.03% -572.35% -138.37% -581.41% -441.14% -758.45% -234.50% -183.68% -996.45% -521.75% 1155.3% -294.09% -120.90% -69.77% -152.34% -125.40% -22.28% 0.0% -39.89% -25.97%
Przychody fiansowe (mln) 2 0 0 5 1 0 0 0 0 0 0 0 0 0 0 5 5 5 18 17 14 17 17 14 12
Koszty finansowe (mln) 0 0 0 0 4 0 0 0 0 0 0 1 1 2 3 5 5 5 6 6 5 5 6 5 5
Amortyzacja (mln) 1 0 0 1 2 3 2 1 4 3 3 4 4 4 5 5 5 3 5 5 6 5 5 7 5
EBITDA (mln) -13 -28 -28 -62 -42 -135 -67 -58 -81 -88 -122 -88 -31 -191 -82 -126 -107 -194 -52 -136 -49 -7 -110 52 -89
EBITDA(%) -127.25% -282.02% -156.78% -316.70% -368.06% -1161.97% -570.05% -141.52% -591.00% -452.38% -508.98% -304.99% -174.07% -1048.60% -503.07% -423.10% -349.13% -120.90% -64.39% -145.60% -119.31% -3.82% -68.61% 28.1% -45.56%
NOPLAT (mln) -12 -28 -28 -62 -48 -135 -67 -58 -81 -92 -125 -88 -41 -193 -85 -136 -112 -199 -62 -147 -60 -18 -121 41 -99
Podatek (mln) 0 0 0 2 -4 79 -1 0 1 0 -3 -4 1 0 0 0 0 0 -0 -2 0 0 4 14 2
Zysk Netto (mln) -12 -29 -28 -64 -44 -135 -67 -58 -81 -92 -125 -88 -42 -193 -85 -136 -112 -199 -62 -145 -60 -18 -125 26 -101
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 255.8% 368.3% 139.4% -9.56% 82.9% -32.10% 88.4% 52.8% -47.98% 111.0% -32.25% 53.8% 166.4% 3.1% -26.78% 6.6% -46.66% -90.86% 101.5% 118.1% 68.8%
Zysk netto (%) -123.64% -285.54% -157.28% -328.76% -383.06% -1162.72% -566.49% -141.79% -591.28% -452.65% -742.76% -226.53% -103.07% -1614.13% -310.50% -491.72% -308.51% -271.55% -64.79% -182.24% -63.62% -9.76% -78.23% 14.1% -51.74%
EPS -0.12 -0.29 -0.28 -0.64 -0.34 -1.25 -0.5 -0.44 -0.61 -0.66 -0.87 -0.6 -0.27 -1.25 -0.27 -0.85 -0.68 -1.14 -0.34 -0.8 -0.33 -0.0996 0.0 0.14 -1.08
EPS (rozwodnione) -0.12 -0.29 -0.28 -0.64 -0.34 -1.25 -0.5 -0.44 -0.61 -0.66 -0.87 -0.6 -0.27 -1.25 -0.27 -0.85 -0.68 -1.14 -0.34 -0.8 -0.33 -0.0996 0.0 0.14 -1.08
Ilośc akcji (mln) 100 100 99 100 129 108 132 132 133 139 145 147 154 155 314 159 165 175 182 182 182 183 0 183 92
Ważona ilośc akcji (mln) 100 100 100 100 129 108 132 132 133 139 145 147 154 155 314 159 165 175 182 182 182 183 0 183 92
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD